Xiao-Chun Xu

2.1k citations
32 papers · 1.7k indexed · h-index 24
Topics
Estrogen and related hormone effects (15 papers)Retinoids in leukemia and cellular processes (14 papers)Inflammatory mediators and NSAID effects (6 papers)

In The Last Decade

Xiao-Chun Xu

32 papers receiving 1.6k citations

Peers

Xiao-Chun Xu
Comparison fields: 5 of 91
  • Molecular Biology 982
  • Cancer Research 432
  • Genetics 413
  • Immunology 343
  • Oncology 309
Replace Jay McQuillan with:
Jay McQuillan United States
Kuo‐Tai Hua Taiwan
B L Kemp United States
Hideyuki Ishiguro Japan
Joanne R. Brown United Kingdom
Nancy Klauber United States
Sophie Raynaud France
Ramzi M. Mohammad United States
Ann L. White United States
T Toge Japan
Xiao-Chun Xu relative to Jay McQuillan United States Jay McQuillan's profile →
Citations per field
00.5×5.4×
Jay McQuillan · 1×
Citations per year

Countries citing papers authored by Xiao-Chun Xu

Since Specialization
Citations

This map shows the geographic impact of Xiao-Chun Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao-Chun Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao-Chun Xu more than expected).

Fields of papers citing papers by Xiao-Chun Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiao-Chun Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao-Chun Xu. The network helps show where Xiao-Chun Xu may publish in the future.

Co-authorship network of co-authors of Xiao-Chun Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiao-Chun Xu. A scholar is included among the top collaborators of Xiao-Chun Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiao-Chun Xu. Xiao-Chun Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 36
2 80
3 26
4 40
5 101
6 19
7 54
8 13
9 37
10 20
11 171
12 38
13 51
14 92
15 49
16 54
17 27
18 36
19 113
20 30

About Xiao-Chun Xu

Xiao-Chun Xu is a scholar working on Genetics, Pharmacology and Biochemistry, having authored 32 papers that have together received 1.7k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (15 papers), Retinoids in leukemia and cellular processes (14 papers) and Inflammatory mediators and NSAID effects (6 papers). The work is most often cited by research in Cancer Research (432 citations), Biochemistry (110 citations) and Immunology (343 citations). Xiao-Chun Xu has collaborated with scholars based in United States, China and Hong Kong. Frequent co-authors include Reuben Lotan, Ashraful Hoque, Hongli Chen, Scott M. Lippman, Shumei Song, T. Mohanakumar, Dafna Lotan, Robert Tressler, Garth L. Nicolson and Paula Belloni. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Immunology and Molecular and Cellular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026